PT - JOURNAL ARTICLE AU - Sheldon M. Singh AU - Neil V. Rau AU - Lawrence B. Cohen AU - Howard Harris TI - Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone AID - 10.1503/cmaj.1040563 DP - 2004 Oct 26 TA - Canadian Medical Association Journal PG - 1063--1064 VI - 171 IP - 9 4099 - http://www.cmaj.ca/content/171/9/1063.short 4100 - http://www.cmaj.ca/content/171/9/1063.full SO - CMAJ2004 Oct 26; 171 AB - INFLIXIMAB IS A CHIMERIC ANTI-TUMOUR NECROSIS FACTOR-α antibody that is efficacious in treating Crohn's disease. However, its immunomodulatory properties increase susceptibility to opportunistic infections. We present a case of cutaneous Nocardia infection in a patient who was taking infliximab for Crohn's disease. The case illustrates the challenges in the diagnosis and management of this disease and serves as a reminder of the complications associated with the use of immunomodulatory agents.